Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Participant Experience topic
No spam. Unsubscribe anytime.
Sickle-cell patient who joined multiple trials urges plain language consent and family support
Summary
Ted Nicolas, who has sickle cell disease and participated in multiple clinical trials including stem-cell research, told the Belmont event that plain-language consent, family involvement and clear communication helped him decide to enroll and cope with trial burdens.
At the Belmont commemoration, Ted Nicolas described his experience as a clinical-trial volunteer for sickle cell therapies and urged researchers to make consent documents understandable and support participants practically. He said clinicians and trial teams should explain risks plainly and recommended journaling and family involvement to help participants communicate symptoms to researchers.
Nicolas, who said he was cured following a stem-cell trial he joined, recounted first learning about trials from clinicians and later seeking information online and from patient groups. "Plain language is a great help," he said, urging researchers to make consent and study processes accessible to people without medical training. His remarks illustrated the human side of ethical protections discussed by the panel and underscored how recruitment and retention depend on trust and communication.
